click below
click below
Normal Size Small Size show me how
krebs
| Term | Definition |
|---|---|
| State where the Krebs cycle occurs. | In the mitochondrial matrix. |
| State the molecule that enters the Krebs cycle. | Acetyl-CoA. |
| Define acetyl-CoA. | A 2-carbon molecule formed from pyruvate during the link reaction. |
| State the first product formed when acetyl-CoA enters the cycle. | Citrate (6-carbon molecule). |
| Explain what happens to citrate in the cycle. | It is gradually oxidized and decarboxylated to regenerate oxaloacetate. |
| Define decarboxylation. | The removal of CO₂ from a molecule. |
| State how many CO₂ molecules are released per turn of the cycle. | Two CO₂ molecules. |
| State the main function of the Krebs cycle. | To generate reduced electron carriers (NADH and FADH₂) for the electron transport chain. |
| List the high-energy products formed per turn of the cycle. | 3 NADH, 1 FADH₂, and 1 ATP (or GTP). |
| State how many NADH are produced per glucose in Krebs. | 6 NADH (because each glucose produces 2 acetyl-CoA). |
| State how many FADH₂ are produced per glucose in Krebs. | 2 FADH₂. |
| State how many ATP are produced per glucose in Krebs. | 2 ATP (one per turn). |
| Explain substrate-level phosphorylation in Krebs. | ATP (or GTP) is generated directly in the cycle without the ETC. |
| Explain why the Krebs cycle is a cycle. | Oxaloacetate is regenerated at the end to react again with acetyl-CoA. |
| Define oxidative decarboxylation. | A reaction that removes CO₂ and reduces NAD+ or FAD simultaneously. |
| State the importance of NADH and FADH₂. | They deliver electrons and hydrogen ions to the electron transport chain for ATP production. |
| Explain why oxygen is required for the Krebs cycle. | Oxygen acts as the final electron acceptor in the ETC; without it, NAD+ and FAD cannot be regenerated. |
| State what happens if NAD+ is not regenerated. | The Krebs cycle stops because NADH accumulates. |
| Explain why the Krebs cycle increases mitochondrial efficiency. | It supplies large amounts of reduced carriers that drive oxidative phosphorylation. |